Shattuck Labs, Inc. (STTK)
5.59
-0.06
(-1.15%)
USD |
NASDAQ |
Oct 08, 11:31
Shattuck Labs Total Liabilities (Quarterly) : 9.531M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.531M |
| March 31, 2026 | 6.286M |
| December 31, 2025 | 8.636M |
| September 30, 2025 | 7.093M |
| June 30, 2025 | 7.352M |
| March 31, 2025 | 9.581M |
| December 31, 2024 | 12.62M |
| September 30, 2024 | 15.14M |
| June 30, 2024 | 18.00M |
| March 31, 2024 | 17.52M |
| December 31, 2023 | 14.86M |
| September 30, 2023 | 17.67M |
| June 30, 2023 | 16.81M |
| March 31, 2023 | 20.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 29.17M |
| September 30, 2022 | 23.52M |
| June 30, 2022 | 28.81M |
| March 31, 2022 | 21.55M |
| December 31, 2021 | 26.80M |
| September 30, 2021 | 49.40M |
| June 30, 2021 | 46.69M |
| March 31, 2021 | 38.19M |
| December 31, 2020 | 39.13M |
| September 30, 2020 | 37.11M |
| June 30, 2020 | 36.46M |
| March 31, 2020 | |
| December 31, 2019 | 30.45M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
| Biogen, Inc. | 13.24B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 220.67M |
| Shareholders Equity (Quarterly) | 211.14M |
| Debt to Equity Ratio | 0.0127 |
| Current Ratio | 27.59 |
| Net Debt Paydown Yield | 0.01% |